Status:

COMPLETED

Transcutaneous Auricular Vagus Nerve Stimulation for Meniere Disease

Lead Sponsor:

Beijing Tongren Hospital

Conditions:

Meniere Disease

Eligibility:

All Genders

18-65 years

Brief Summary

Objective: To evaluate the effect of Transcutaneous auricular vagus nerve stimulation for the patients Meniere disease. Methods: We enrolled 231 patients at Beijing TongRen Hospital. All treatments w...

Eligibility Criteria

Inclusion

  • 1\. Age \>=18 and Age \<=65. 2. Clinical diagnosis of meniere disease.

Exclusion

  • History of depression, tumors, thyroid disease, diabetes, cardiac diseases.
  • History of Otorhinolaryngology surgery.
  • Pregnant or lactating women.

Key Trial Info

Start Date :

January 1 2019

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

July 10 2024

Estimated Enrollment :

77 Patients enrolled

Trial Details

Trial ID

NCT06544590

Start Date

January 1 2019

End Date

July 10 2024

Last Update

August 9 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

China Beijing TongRen Hospital, Capital Medical University Beijing, China

Beijing, Beijing Municipality, China, 100730

Transcutaneous Auricular Vagus Nerve Stimulation for Meniere Disease | DecenTrialz